cryptotreasury

It will not move ahead with plans to remove digital asset treasury firms from its indexes for now. The stock rose close to six percent in post market trading. This decision brought short term relief to Strategy and similar companies that hold large amounts of bitcoin on their balance sheets.
Strategy is known for holding bitcoin as a core part of its treasury. It does not run a blockchain network or build crypto products. Because of this it was at risk if MSCI decided to change its index rules. If the company had been removed from major indexes many large investors would have been forced to sell the stock. That could have caused strong selling pressure and lower prices.
MSCI choosing not to act right now helped reduce that risk. Investors reacted quickly and pushed the stock higher. For many holders this news was a positive surprise. It showed that MSCI was willing to listen to feedback and slow down before making a final decision.
Some analysts welcomed the move but stayed careful about what comes next. One analyst said the decision was clearly positive but warned that it may only be temporary. The main concern is that MSCI could still update its rules later. If that happens companies like Strategy could once again face removal from indexes.
Another analyst who is very positive on the stock said the decision was a relief. He believes the company made a strong case for staying in the indexes. Still he also noted that MSCI is continuing to review how it treats companies that do not have traditional operations. This means the discussion is not fully closed.
The situation matters beyond just one company. Many firms now hold digital assets as part of their treasury strategy. If future rules treat these firms differently it could change how public companies manage bitcoin on their balance sheets. It could also affect how investors view stocks that are closely tied to digital assets.
For now the market mood is calm but careful. There is optimism because the worst case outcome did not happen. At the same time there is awareness that rules can change. Strategy remains in the indexes and continues its approach of holding bitcoin long term.
This moment shows how traditional finance and digital assets are still adjusting to each other. Index providers investors and companies are all learning how to handle this new type of balance sheet. The latest decision gives Strategy time and space but it does not guarantee long term certainty.
At least for now investors are taking the news as a positive sign. The pressure has eased and the stock has responded. What happens next will depend on future decisions and how digital asset treasury companies are defined going forward.#Strategy #Bitcoin #CryptoTreasury #DigitalAssets

$AVAX
Avalanche ($AVAX ) is pivoting from a tech narrative to a financial one. The foundation is buying back tokens to seed "Treasury Companies," and Anthony Scaramucci has endorsed it as a "Top 2026 Pick," driving significant demand.

Avalanche is attempting to fix its tokenomics through a stock buyback-style program disguised as ecosystem growth. By locking up supply in these treasury companies, they are creating an artificial price floor. While critics argue this is necessary because organic demand has moved to Solana, supporters see it as mature treasury management.

If this financial engineering works, other foundations like Polkadot or Near will likely copy the meta. It shifts the industry away from "ecosystem grants" and toward hoarding and price support.
Traders are focused on the $50 psychological barrier and the outcome of Bitwise’s $AVAX ETF filing. Rumors of major banks like JP Morgan launching subnets continue to circulate.
Avalanche is positioning itself as the "Financial Layer" of crypto for the institutional era.
Scaramucci says buy AVAX. Are you following the "Mooch" or fading the suit?


#AVAX #Avalanche #Scaramucci #CryptoTreasury

1. BIOTECH FIRM TO TRANSFORM INTO CRYPTO TREASURY ENTITY
2. NEW COMPANY TO HOLD $583M IN HYPE TOKENS + $305M CASH
Nasdaq-listed Sonnet BioTherapeutics is set to merge with Rorschach I LLC, shifting its core focus from biotechnology to crypto treasury management under the new name Hyperliquid Strategies Inc. (HSI).
Key Details:
Valuation: $888 million
HYPE Token Holdings: 12.6M tokens (~$583M)Cash Reserves: $305MTicker: New Nasdaq symbol post-mergerInvestors: Paradigm, Galaxy Digital, Pantera, Republic, D1 Capital, 683 CapitalHSI will lead crypto treasury operations using Hyperliquid’s Layer-1 blockchain, with $HYPE as its central asset. Some biotech programs like SON-1010 will continue under retained operations
.Leadership Changes:
Chairman: Bob Diamond (Atlas Merchant Capital)
CEO: David Schamis (Atlas CIO)Board Additions: Eric Rosengren (ex-Boston Fed), Sonnet independentsPrivate Placement & Funding:
$5.5M raised via convertible preferred stock & warrants
$2M in convertible notes to convert into equityProceeds to support biotech and deal expensesOwnership Post-Merger:
Rorschach & New Investors: 98.8%
Sonnet Stakeholders: 1.2%Market Outlook: A bold pivot from biotech to blockchain—positioning HSI as a major crypto asset manager on Nasdaq.
#CryptoMerger ##USCryptoWeek #SonnetBio #Hyperliquid #CryptoTreasury

IVD Medical Holdings, a publicly traded healthcare firm in Hong Kong, has added $19 million worth of Ether $ETH (ETH) to its corporate treasury — but it’s not just for holding.

The company plans to use ETH as the core infrastructure asset for its tokenization platform, ivd.xyz, aimed at transforming how pharmaceutical intellectual property and other healthcare assets are managed on-chain.

🧬 ETH at the Heart of Healthcare Tokenization

According to IVD’s Chief Strategy Officer Gary Deng, Ethereum was chosen because it’s the:

“World’s most mature smart contract platform”

Highly liquid

Gaining growing institutional approval, including a spot ETH ETF in the U.S.

Here’s what ETH will be used for:

Ownership confirmation of tokenized assets

Automated revenue distribution

Compliance governance

Backing for IVDD stablecoin

Settlement layer for cross-border healthcare transactions

💰 Beyond HODLing: Staking, Derivatives, and Yield

IVD plans to actively deploy ETH into:

Staking and re-staking

On-chain derivatives

Yield strategies to boost returns while maintaining liquidity and downside protection

This strategy aligns IVD with a growing trend of Hong Kong-listed firms allocating treasury to crypto — but with a more utility-driven approach compared to passive BTC $BTC holdings.

🤝 Strategic Partnership with HashKey

The move follows a partnership with HashKey Group, one of the few licensed crypto platforms in Hong Kong. HashKey will likely play a key role in enabling compliant infrastructure for ETH-backed healthcare finance solutions.

📈 A Growing List of HK Crypto Treasuries

IVD joins a small but growing club of Hong Kong-listed crypto treasuries:

Boyaa Interactive holds over 3,100 BTC

Meitu previously bought 31,000 ETH and 940 BTC

Smaller holders include Yuxing, Moon Inc., and Walnut Capital

But unlike others, IVD is using ETH not just as an asset — but as a foundation for innovation in healthcare tokenization.

Will tokenized real-world assets (RWAs) become the next big crypto use case?

#Ethereum #Tokenization #IVDMedical #CryptoTreasury #HealthcareBlockchain